Psychopharmacology.
D000437:Alcoholism / Q000150:complications / Q000188:drug therapy; D001007:Anxiety; D001925:Brain Damage, Chronic / Q000209:etiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D000431:Ethanol / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008620:Meprobamate / Q000494:pharmacology; D010640:Phenothiazines / Q000008:administration & dosage; D010879:Piperazines / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D011600:Psychopharmacology; D012110:Reserpine / Q000627:therapeutic use; D012173:Retinitis / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000627:therapeutic use*; D014966:Xanthenes / Q000627:therapeutic use*
D010640:Phenothiazines; D010879:Piperazines; D014966:Xanthenes; D014268:Trifluoperazine; D000431:Ethanol; D012110:Reserpine; D008620:Meprobamate; D011433:Propranolol; D013881:Thioridazine